Smoking cessation and adults with serious mental illness: The Need for More Research at Every Step of the Quit Process

Nicotine and Tobacco Research

Volumn 18, Issue 3, 2016, Pages 227-228

  Weinberger, Andrea H ^a,b  

^a YESHIVA UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO; VARENICLINE;

ADULT; BIPOLAR DISORDER; COGNITIVE THERAPY; EDITORIAL; HUMAN; MENTAL DISEASE; MOBILE APPLICATION; MOTIVATION; MOTIVATIONAL INTERVIEWING; NICOTINE REPLACEMENT THERAPY; PREVALENCE; PRIORITY JOURNAL; RELAPSE; SMOKING CESSATION; TOBACCO USE; VIDEOCONFERENCING; RESEARCH; SMOKING; TOBACCO DEPENDENCE;

ADULT; HUMANS; MENTAL DISORDERS; RESEARCH; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84962909485     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv288     Document Type: Editorial

References (14)

1. Williams JM, Steinberg ML, Griffiths KG, Cooperman N. Smokers with behavioral health comorbidity should be designated a tobacco use disparity group. Am J Public Health. 2013;103(9):1549-1555. doi:10.2105/AJPH.2013.301232.
2. Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23(e2):e147-e153. doi:10.1136/tobaccocontrol-2013-051466.
3. CDC. Vital signs: current cigarette smoking among adults aged =18 years with mental illness-United States, 2009-2011. Morb Mortal Wkly Rep. 2013;62(5):1-7.
4. Szatkowski L, McNeill A. Diverging trends in smoking beahviors according to mental health status. Nicotine Tob Res. 2015;17(3):356-360. doi:10.1093/ntr/ntu173c.
5. Steinberg ML, Williams JM, Stahl NF, Budsock PD, Cooperman NA. An adaptation of motivational interviewing increases quit attempts in smokers with serious mental illness. Nicotine Tob Res. 2016;18(3):243-250. doi:10.1093/ntr/ntv043.
6. Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control. 2010;19(5):410-416. doi:10.1136/tc.2009.033175
7. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: U.S. Department of Health and Human Services; 2008.
8. Roberts E, Evins AE, McNeill A, Robson D. Efficacy and acceptability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis [published online ahead of print November 23, 2015]. Addiction. doi:10.1111/add.13236.
9. Whittaker R, McRobbie H, Bullen C, Borland R, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD006611. doi:10.1002/14651858.CD006611.pub3.
10. Brunette MF, Dzebisashvilim N, Xie H, Akerman S, Ferron JC, Bartels S. Expanding cessation pharmacotherapy via videoconference educational outresearch to prescribers. Nicotine Tob Res. 2015;17(8):960-967. doi:10.1093/ntr/ntv006.
11. Vilardaga R, Rizo J, Kientz JA, McDonell MG, Ries RK, Sobel K. User experience evaluation of a smoking cessation app in people with serious mental illness [published online ahead of print November 17, 2015]. Nicotine Tob Res. doi:10.1093/ntr/ntv256.
12. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34(2):102-111. doi:10.1016/j.amepre.2007.09.033.
13. Hajek P, Stead LF, West R, Jarvis M, Hartmann-Boyce J, Lancaster T. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. 2013;8:CD003999. doi:10.1002/14651858.CD003999.pub4.
14. Evins AE, Cather C, Pratt SA, et al. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA. 2014;311(2):145-152. doi:10.1001/jama.2013.285113.